First Manhattan »

Lineage Cell Therapeutics In shares owned by First Manhattan

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by First Manhattan from 13F filings

Historical chart of First Manhattan investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by First Manhattan consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by First Manhattan

Quarter filed Position value Share count Share price at filing
2024-03-31 $138 94 1.48
2023-09-30 $109 94 1.17
2023-06-30 $132 94 1.40
2023-03-31 $141 94 1.50
2022-12-31 $109 94 1.16
2022-09-30 $0 94 0.00
2022-06-30 $0 94 0.00
2022-03-31 $0 94 0.00
2021-12-31 $0 94 0.00
2021-09-30 $0 94 0.00
2021-06-30 $5.0k 2.1k 2.39
2021-03-31 $0 94 0.00
2020-12-31 $0 94 0.00
2020-09-30 $0 94 0.00
2020-06-30 $0 94 0.00
2020-03-31 $0 94 0.00
2019-12-31 $0 94 0.00
2019-09-30 $0 94 0.00